Physician profile
Young H Lee
NPI 1194889972
$12,929.03
in general payments reported to CMS, 2019-2025
37 companies · $1,761 in 2025
The $1,761 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,293 · 2020: $1,106 · 2021: $1,202 · 2022: $2,570 · 2023: $2,625 · 2024: $2,372 · 2025: $1,761.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,398 · Education: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,398.06 |
| Education | $360.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,913.22 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,996.29 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Astrazeneca Pharmaceuticals LP | $1,816.07 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Actelion Pharmaceuticals US, INC. | $1,286.64 | 2019-2025 | Opsumit, Uptravi |
| Regeneron Healthcare Solutions, INC. | $632.97 | 2021-2025 | Dupixent |
| Genzyme Corporation | $585.33 | 2021-2025 | |
| Philips North America LLC | $398.50 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Baxter Healthcare | $373.43 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System, Hillrom - Volara System |
| United Therapeutics Corporation | $301.26 | 2021-2025 | Tyvaso, Tyvaso |
| Verona Pharma, INC. | $277.89 | 2025 | Ohtuvayre |
| Sanofi-Aventis U.S. LLC | $260.57 | 2021-2025 | |
| Grifols USA, LLC | $250.08 | 2019-2024 | Prolastin-C Liquid |
| Insmed, INC. | $243.90 | 2021-2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $220.77 | 2020-2024 | Yupelri |
| Genentech USA, INC. | $181.12 | 2019-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $149.35 | 2023-2025 | Winrevair |
| Janssen Pharmaceuticals, INC | $139.91 | 2020-2022 | |
| Advanced Respiratory, INC | $112.53 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $80.60 | 2020-2022 | |
| Electromed, INC. | $78.51 | 2019-2023 | Smartvest |
| Covis Pharma Gmbh | $70.06 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $66.68 | 2024-2025 | Glassia |
| Phadia US INC. | $58.64 | 2023-2024 | Immunocap |
| Pulmonx Corporation | $56.90 | 2019-2023 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Amgen INC. | $49.81 | 2025 | Tezspire |
| Gilead Sciences, INC. | $49.56 | 2021-2023 | Veklury |
| Pfizer INC. | $45.33 | 2020-2023 | |
| Abbott Laboratories | $41.03 | 2023-2024 | Cardiomems |
| Ani Pharmaceuticals, INC. | $27.43 | 2025 | Purified Cortrophin Gel |
| Teleflex LLC | $25.69 | 2024 | Guideliner |
| Abbvie INC. | $25.00 | 2023 | |
| Vifor Pharma, INC. | $24.39 | 2024 | Zemaira |
| Jazz Pharmaceuticals INC. | $23.27 | 2020 | |
| Nabriva Therapeutics, Plc | $20.92 | 2022 | |
| Shire North American Group INC | $19.31 | 2019 | |
| Breas Medical, INC. | $13.89 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Young Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.